Jonathan Sheena sold $745k of NTRA
director, other at Natera, Inc.. 5,700 shares at an average of $130.78, traded Nov 8, 2024, filed Nov 12, 2024.
Score components
- +15RoleDirector
- +21Trade size$745k at market
- 0Share of holdings soldSold 2.0% of holdings
- +15Cluster8 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +23.2%, 3m +25.6%, 6m +12.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-026658, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | SOpen-market sale Common Stock10b5-1 | -360 | $129.78 | $47k | 282,112 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stock10b5-1 | -2,171 | $130.89 | $284k | 279,941 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stock10b5-1 | -169 | $131.85 | $22k | 279,772 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -736 | $130.40 | $96k | 56,696 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -764 | $131.14 | $100k | 55,932 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -998 | $130.47 | $130k | 56,434 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -412 | $131.24 | $54k | 56,022 | Nov 12, 2024 |
| Nov 8, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -90 | $131.84 | $12k | 55,932 | Nov 12, 2024 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $526k 1,273 shares | -1% | |
| 40Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $1.2M 3,000 shares | -3% | |
| 55Moderate | Natera, Inc. | Jonathan Sheena director, other | $7.0M 18,064 shares | -100% | |
| 35Weak | Natera, Inc. | Jonathan Sheena director, other | $3.2M 9,150 shares | -4% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $35M 102,000 shares | -5% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $16M 50,000 shares | -2% | |
| 39Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $545k 1,698 shares | -2% | |
| 45Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $5.9M 18,160 shares | -14% | |
| 27Weak | Natera, Inc. | Michael Burkes Brophy CHIEF FINANCIAL OFFICER | $116k 792 shares | -1% | |
| 45Moderate | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $979k 6,702 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.